A Phase 1 First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 427 in Subjects with Relapsed/Refractory Acute Myeloid Leukemia.

  • Wei, Andrew (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

StatusActive
Effective start/end date9/07/1931/12/24

Keywords

  • Malignant Haematology
  • Acute Myeloid Leukemia (AML)
  • Clinical Trial
  • Malignant Haematology
  • Acute Myeloid Leukemia (AML)
  • Clinical Trial
  • Malignant Haematology
  • Acute Myeloid Leukemia (AML)
  • Clinical Trial